David Gordon

ORCID: 0000-0003-3276-9685
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antimicrobial Resistance in Staphylococcus
  • Complement system in diseases
  • Atrial Fibrillation Management and Outcomes
  • African history and culture studies
  • Cardiac electrophysiology and arrhythmias
  • Infective Endocarditis Diagnosis and Management
  • Bacterial Identification and Susceptibility Testing
  • Cardiac Arrhythmias and Treatments
  • Monoclonal and Polyclonal Antibodies Research
  • Streptococcal Infections and Treatments
  • Political Economy and Marxism
  • Pelvic floor disorders treatments
  • Respiratory viral infections research
  • Astronomical Observations and Instrumentation
  • Global Maritime and Colonial Histories
  • Clostridium difficile and Clostridium perfringens research
  • Blood Coagulation and Thrombosis Mechanisms
  • Gut microbiota and health
  • Pneumonia and Respiratory Infections
  • Acute Ischemic Stroke Management
  • Bacterial Infections and Vaccines
  • Lipoproteins and Cardiovascular Health
  • African history and culture analysis
  • Antifungal resistance and susceptibility
  • Economic Theory and Policy

Flinders Medical Centre
2015-2024

South Australia Pathology
2015-2024

Flinders University
2013-2024

University of Oklahoma Health Sciences Center
2014-2024

SA Health
2020-2024

Western Health
2024

San Francisco General Hospital
2024

Nuffield Health
2024

Bristol-Myers Squibb (United States)
2001-2024

National Health and Medical Research Council
2024

The etiology of ischemic stroke affects prognosis, outcome, and management. Trials therapies for patients with acute should include measurements responses as influenced by subtype stroke. A system categorization subtypes mainly based on has been developed the Trial Org 10172 in Acute Stroke Treatment (TOAST). classification was prepared using clinical features results ancillary diagnostic studies. "Possible" "probable" diagnoses can be made physician's certainty diagnosis. usefulness...

10.1161/01.str.24.1.35 article EN Stroke 1993-01-01

Preface 1. The historical transformation of labor: an overview 2. Long swings and stages capitalism 3. Initial proletarianization: 1820s to 1890s 4. the homogenization 1870s World War II 5. segmentation 1920s present 6. A recapitulation Notes Bibliography Index.

10.2307/1866787 article EN The American Historical Review 1987-04-01

10.2307/218991 article EN The International Journal of African Historical Studies 1986-01-01

The durability of infection-induced SARS-CoV-2 immunity has major implications for reinfection and vaccine development. Here, we show a comprehensive profile antibody, B cell T dynamics over time in cohort patients who have recovered from mild-moderate COVID-19. Binding neutralising antibody responses, together with individual serum clonotypes, decay the first 4 months post-infection. A similar decline Spike-specific CD4+ circulating follicular helper frequencies occurs. By contrast,...

10.1038/s41467-021-21444-5 article EN cc-by Nature Communications 2021-02-19

To assess the efficacy and safety of subcutaneous (SC) belimumab in patients with systemic lupus erythematosus (SLE).Patients moderate-to-severe SLE (score ≥8 on Safety Estrogens Lupus Erythematosus National Assessment [SELENA] version Disease Activity Index [SLEDAI]) were randomized 2:1 to receive weekly SC 200 mg or placebo by prefilled syringe addition standard therapy for 52 weeks. The primary end point was Responder (SRI4) at week 52. Secondary points reduction corticosteroid dosage...

10.1002/art.40049 article EN cc-by-nc Arthritis & Rheumatology 2017-01-24

Intravenous belimumab plus standard of care (SoC) is approved in the USA and Europe for treatment active, autoantibody-positive systemic lupus erythematosus (SLE).This phase III, multicentre, randomised, double-blind, placebo-controlled study (BEL113750; NCT01345253) was conducted 49 centres across China, Japan South Korea (May 2011-September 2015). Patients with SLE were randomised 2:1 to intravenous 10 mg/kg or placebo, SoC, every 4 weeks until Week 48. The primary endpoint Responder Index...

10.1136/annrheumdis-2017-211631 article EN cc-by-nc Annals of the Rheumatic Diseases 2018-01-02
Lawrence P. Park Vivian H. Chu Gail Peterson Athanasios Skoutelis Tatjana Lejko-Zupa and 95 more Emilio Bouza Pierre Tattevin Gilbert Habib Ren Tan Javier González Javier Altclas Jameela Edathodu Cláudio Querido Fortes Rinaldo Focaccia Siciliano Orathai Pachirat Souha S. Kanj Andrew Wang Liliana Clara Marisa Sánchez José Casabé Claudia Cortés Francisco Nacinovich P. Fernandez Oses Ricardo Ronderos Adriana Sucari Jorge Thierer Silvia Kogan Denis Spelman Eugene Athan Owen Harris Karina Kennedy David Gordon Lito E. Papanicolas Tony M. Korman Despina Kotsanas Robyn Dever P. D. Jones Pam Koneçny Richard Lawrence David Rees Suzanne Ryan Michael P. Feneley John Harkness P. D. Jones Suzanne Ryan P. D. Jones Suzanne Ryan P. D. Jones Jeffrey J. Post Porl Reinbott Suzanne Ryan Rainer Gattringer Franz Wiesbauer Adriana Ribas Andrade Ana Cláudia Passos de Brito Armênio Costa Guimarães Max Grinberg Alfredo José Mansur Tânia Mara Varejão Strabelli Marcelo Luiz Campos Vieira Regina Aparecida de Medeiros Tranchesi Marcelo Goulart Paiva Auristela de Oliveira Ramos Clara Weksler G. Ferraiuoli W. Golebiovski Cristiane da Cruz Lamas James A. Karlowsky Yoav Keynan Andrew M. Morris Ethan Rubinstein Sandra Braun Jones Patricia García Alberto Fíca Rodrigo Montagna Mella Ricardo Fernández Liliana Franco Astrid Natalia Jaramillo Bruno Baršić Suzana Bukovski Vladimir Krajinović Ana Pangerčić Igor Rudež Josip Vincelj Tomáš Freiberger Jiří Pol Barbora Žaloudíková Zainab Ashour Amani El Kholy Marwa Mishaal Dina Osama Hussien Rizk N. Aissa Corentine Alauzet François Alla Catherine Campagnac Thanh Doco‐Lecompte Christine Selton‐Suty Jean‐Paul Casalta Pierre‐Edouard Fournier

Host factors and complications have been associated with higher mortality in infective endocarditis (IE). We sought to develop validate a model of clinical characteristics predict 6-month IE.Using large multinational prospective registry definite IE (International Collaboration on Endocarditis [ICE]-Prospective Cohort Study [PCS], 2000-2006, n=4049), survival was developed by Cox proportional hazards modeling inverse probability weighting for surgery treatment internally validated the...

10.1161/jaha.115.003016 article EN cc-by-nc-nd Journal of the American Heart Association 2016-04-03
Christina Reith David Preiss Lisa Blackwell Jonathan Emberson Enti Spata and 95 more Kelly Davies Heather Halls Charlie Harper Lisa Holland Kate Wilson Alistair Roddick Christopher P. Cannon Robert Clarke Helen M. Colhoun Paul N. Durrington Shinya Goto G. A. Hitman G. Kees Hovingh J. Wouter Jukema Wolfgang Köenig Ian C. Marschner Borislava Mihaylova Connie B. Newman Jeffrey L Probsfield Paul M. Ridker Marc S. Sabatine Naveed Sattar Gregory G. Schwartz Luigi Tavazzi Andrew Tonkin Stella Trompet Harvey D. White Salim Yusuf Jane Armitage Anthony Keech John Simes Rory Collins Colin Baigent Elizabeth H Barnes Jordan Fulcher William G. Herrington Adrienne Kirby Rachel O’Connell Pierre Amarenco Hiroyuki Arashi Philip J. Barter D. J. Betteridge Michael A. Blazing Gerard J Blauw Jackie Bosch Louise Bowman Eugene Braunwald Richard Bulbulia Robert Byington Michael Clearfield Stuart M. Cobbe Björn Dahlöf Barry R. Davis James A. de Lemos John R. Downs Bengt Fellström Marcus Flather Ian Ford Maria Grazia Franzosi John A. Fuller Curt D. Furberg Robert J. Glynn Uri Goldbourt David Gordon Antonio M. Gotto Richard Grimm A Gupta C Hawkins Richard Haynes Hallvard Holdaas Jemma C. Hopewell Alan G. Jardine John J.P. Kastelein Sharon Kean Patricia M. Kearney George D. Kitas John Kjekshus Genell L. Knatterud Robert H. Knopp Michael J. Koren Vera Krane Martin Landray John C. LaRosa Roberto Latini Eva Lonn Donata Lucci Jean MacFadyen Peter W. Macfarlane Stephen MacMahon Aldo P. Maggioni Roberto Marchioli Lemuel A. Moyé Sabina A. Murphy Andrew Neil Enrico Nicolis

Previous meta-analyses of summary data from randomised controlled trials have shown that statin therapy increases the risk diabetes, but less is known about size or timing this effect, who at greatest risk. We aimed to address these gaps in knowledge through analysis individual participant large, long-term, randomised, double-blind therapy.

10.1016/s2213-8587(24)00040-8 article EN cc-by The Lancet Diabetes & Endocrinology 2024-03-27

Abstract Factor H, a regulator of complement activation, contains 20 short consensus repeat (SCR) domains common among the family C3b/C4b-binding proteins. Chinese hamster ovary cells transfected with cDNA corresponding to N-terminal tryptic fragment factor H (containing SCR 1-5 and part 6) secreted protein cofactor activity for I-dependent cleavage C3b. A series deletion mutants, each lacking one first five SCR, were constructed, supernatants tested activity. Supernatants 1, 4, 5 mutants...

10.4049/jimmunol.155.1.348 article EN The Journal of Immunology 1995-07-01

Abstract Complement factor H (fH) regulates activation of the alternative pathway C, reducing amount C3b deposited on sialic acid-rich surfaces. Heparin binding has been used as a model for examining acid-binding characteristics fH. We have previously shown that 20 short consensus repeat (SCR) modules fH, SCR 7 contains an important heparin site, but other SCRs also play role in binding. To localize sites, we prepared recombinant truncated and deletion mutants fH tested them by...

10.4049/jimmunol.160.7.3342 article EN The Journal of Immunology 1998-04-01

This paper seeks to explain trends in United States corporate profitability since World War II through an analysis of the rise and subsequent demise a postwar social structure accumulation (SSA). Building from formal model determinants profitability, we provide econometric support for hypothesis that variations can be explained large extent by quantitative indicators capitalist power SSA.

10.1177/048661348601800107 article EN Review of Radical Political Economics 1986-03-01

Abstract Surface polyanions such as sialic acid and heparin are thought to enhance the binding of complement factor H (fH) C3b deposited on particles cell surfaces, thereby reducing activation. fH contains 20 short consensus repeat (SCR) domains, it has been proposed that SCR 13 a site. We used recombinant proteins determine site fH. Full-length (H20) truncated deletion mutant were cloned expressed in Chinese hamster ovary cells. Supernatants applied heparin-agarose affinity columns their...

10.4049/jimmunol.157.12.5422 article EN The Journal of Immunology 1996-12-15

Coagulase-negative staphylococci (CoNS) are an infrequent cause of native valve endocarditis (NVE), and our understanding NVE caused by CoNS is incomplete.The International Collaboration on Endocarditis-Prospective Cohort Study includes patients with from 61 centers in 28 countries. Patients definite cases who were enrolled during the period June 2000-August 2006 compared Staphylococcus aureus viridans group streptococci. Multivariable logistic regression was used to determine factors...

10.1086/524666 article EN Clinical Infectious Diseases 2007-12-04
Coming Soon ...